Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nichi-Iko Pharmaceutical
Asia
Daiichi Sankyo, AstraZeneca, Fujifilm and more—FiercePharmaAsia
Daiichi attracts AZ to its anti-TROP ADC but loses Sanofi in vaccine program. AZ's China growth slows. Fufjifilm signs on to make COVID vaccine.
Angus Liu
Jul 31, 2020 9:50am
Teva, Takeda downsize Japanese joint venture with asset sell-off
Jul 30, 2020 9:30am
Sanofi cuts, CEOs' Chinese names and more—FiercePharmaAsia
Oct 4, 2019 10:00am
Sartan recall, China high-tech board and more—FiercePharmaAsia
Mar 8, 2019 10:30am
Sagent buys U.S. sterile injectables plant for parent Nichi-Iko
Mar 4, 2019 1:01pm
Japan’s Sawai gets U.S. sites in Upsher-Smith generics deal
Jun 5, 2017 2:04pm
